Identification of Rad51 alteration in patients with bilateral breast cancer

被引:0
|
作者
M. Kato
K. Yano
F. Matsuo
H. Saito
T. Katagiri
H. Kurumizaka
M. Yoshimoto
F. Kasumi
F. Akiyama
G. Sakamoto
H. Nagawa
Y. Nakamura
Y. Miki
机构
[1] Department of Molecular Diagnosis,
[2] Cancer Institute,undefined
[3] 1-37-1 Kamiikebukuro,undefined
[4] Toshima-ku,undefined
[5] Tokyo 170-8455,undefined
[6] Japan Tel. +81-3-5394-4035; Fax +81-3-5394-4035 e-mail: yosmiki@ims.u-tokyo.ac.jp,undefined
[7] Department of Surgical Oncology,undefined
[8] Faculty of Medicine,undefined
[9] The University of Tokyo,undefined
[10] Tokyo,undefined
[11] Japan,undefined
[12] Cancer Genetics Laboratory,undefined
[13] Division of Medical and Molecular Genetics,undefined
[14] Guy's,undefined
[15] King's and St. Thomas' School of Medicine,undefined
[16] London,undefined
[17] UK,undefined
[18] Cellular Signaling Laboratory,undefined
[19] The Institute of Physical and Chemical Research (RIKEN),undefined
[20] Saitama,undefined
[21] Japan,undefined
[22] Department of Breast Surgery,undefined
[23] Cancer Institute Hospital,undefined
[24] Tokyo,undefined
[25] Japan,undefined
[26] Department of Pathology,undefined
[27] Cancer Institute,undefined
[28] Tokyo,undefined
[29] Japan,undefined
[30] Human Genome Center,undefined
[31] Institute of Medical Science,undefined
[32] University of Tokyo,undefined
[33] Tokyo,undefined
[34] Japan,undefined
来源
Journal of Human Genetics | 2000年 / 45卷
关键词
Key wordsRad51; Hereditary breast cancer; BRCA1; BRCA2; Germline alteration;
D O I
暂无
中图分类号
学科分类号
摘要
The human Rad51 gene, HsRAD51, is a homolog of RecA of Escherichia coli and functions in recombination and DNA repair. BRCA1 and BRCA2 proteins form a complex with Rad51, and these genes are thought to participate in a common DNA damage response path-way associated with the activation of homologous recombination and double-strand break repair. Additionally, we have shown that the pattern of northern blot analysis of the Rad51 gene is closely similar to those of the BRCA1 and BRCA2 genes. It is therefore possible that alterations of the Rad51 gene may be involved in the development of hereditary breast cancer. To investigate this possibility, we screened Japanese patients with hereditary breast cancer for Rad51 mutations and found a single alteration in exon 6. This was determined to be present in the germline in two patients with bilateral breast cancer, one with synchronous bilateral breast cancer and the other with synchronous bilateral multiple breast cancer. In both patients, blood DNAs showed a G-to-A transition in the second nucleotide of codon 150, which results in the substitution of glutamine for arginine. As this alteration was not present in any patients with breast or colon cancer examined, we assume that this missense alteration is likely to be a disease-causing mutation.
引用
收藏
页码:133 / 137
页数:4
相关论文
共 50 条
  • [31] CHANGES IN MODIFYING GENES XPC AND RAD51 INCREASE BREAST CANCER SUSCEPTIBILITY IN PATIENTS WITH BRCA MUTATIONS
    Shapira, Iuliana
    Arenare, Elizabeth
    Shih, Andrew
    Oswald, Michaela
    Mason, Cathleen
    Keogh, Mary
    Lee, Annette
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (04) : 766 - 766
  • [32] RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study
    Le Calvez-Kelm, Florence
    Oliver, Javier
    Damiola, Francesca
    Forey, Nathalie
    Robinot, Nivonirina
    Durand, Geoffroy
    Voegele, Catherine
    Vallee, Maxime P.
    Byrnes, Graham
    Hopper, John L.
    Southey, Melissa C.
    Andrulis, Irene L.
    John, Esther M.
    Tavtigian, Sean V.
    Lesueur, Fabienne
    PLOS ONE, 2012, 7 (12):
  • [33] Identification and characterization of potent RAD51 inhibitors targeting RAD51-BRCA2 interaction
    Sasmal, Sanjita
    Patra, Sukanya
    Boorgu, Venkatesham
    Yanamandra, Mahesh
    Chithaluri, Shankar
    Pathange, Hema Sankar
    Hiremath, Deepika
    Girme, Sandeep M.
    Pawar, Amit Kumar
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [34] XRCC3 and RAD51 Expression Are Associated with Clinical Factors in Breast Cancer
    Hu, Jia
    Wang, Ning
    Wang, Ya-Jie
    PLOS ONE, 2013, 8 (08):
  • [35] RAD51 at the heart of the balance between cancer and aging
    Matos-Rodrigues, Gabriel
    Lopez, Bernard S.
    Martini, Emmanuelle
    M S-MEDECINE SCIENCES, 2024, 40 (03): : 234 - 237
  • [36] Overexpression of RAD51 occurs in aggressive prostatic cancer
    Mitra, Anita
    Jameson, Charles
    Barbachano, Yolanda
    Sanchez, Lydia
    Kote-Jarai, Zsofia
    Peock, Susan
    Sodha, Nayanta
    Bancroft, Elizabeth
    Fletcher, Anne
    Cooper, Colin
    Easton, Douglas
    Eeles, Rosalind
    Foster, Christopher S.
    HISTOPATHOLOGY, 2009, 55 (06) : 696 - 704
  • [37] The RAD51 gene family, genetic instability and cancer
    Thacker, J
    CANCER LETTERS, 2005, 219 (02) : 125 - 135
  • [38] Clinicopathological and Prognostic Characteristics of RAD51 in Colorectal Cancer
    Lee, Jae-Ho
    Bae, An-Na
    Jung, Soo-Jung
    MEDICINA-LITHUANIA, 2020, 56 (02):
  • [39] Clinical Relevance of RAD51 Expression in Colorectal Cancer
    Abdelfatah, Eihab N.
    Wu, Rongrong
    Takabe, Kazuaki
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 427 - 427
  • [40] Rad51 expression is associated with estrogen and progesteron receptor status in sporadic breast cancer
    Barbano, Raffaele
    Copetti, Massimiliano
    Muscarella, Lucia Anna
    Balsamo, Teresa
    Poeta, Maria Luana
    la Torre, Annamaria
    Murgo, Roberto
    Bisceglia, Michele
    Maiello, Evaristo
    Pellegrini, Fabio
    Latiano, Tiziana
    Valori, Vanna Maria
    Perrone, Giuseppe
    Altomare, Vincenzo
    Fazio, Vito Michele
    Parrella, Paola
    CANCER RESEARCH, 2010, 70